Showing results (311-320 of 1,288) with videos related to
Sort By:
Pageof 129
Paediatric Drugs|April 10, 2025
Risk Factors for Nephrotoxicity Among Neonates Receiving Vancomycin: A Systematic Review and Meta-analysisYuan Gao, Tong Wu, Libin Pu, et al.Paediatric Drugs|March 22, 2025
Unveiling the Complexities of Pediatric Asthma Treatment: Evidence, Controversies, and Emerging ApproachesMaria Elisa Di Cicco, Diego Peroni, Gian Luigi Marseglia, et al.Paediatric Drugs|March 8, 2025
Diagnosis and Oral Sirolimus Treatment of Fibro-Adipose Vascular Anomaly in Pediatric Patients: A Case Series and Comprehensive ReviewRui He, Jie Yin, Nan Zhang, et al.Paediatric Drugs|May 16, 2024
Personalized Dosing of Medicines for Children: A Primer on Pediatric Pharmacometrics for CliniciansKevin Meesters, Violeta Balbas-Martinez, Karel Allegaert, et al.Paediatric Drugs|April 17, 2024
Population Pharmacokinetics of Adalimumab in Juvenile Idiopathic Arthritis Patients: A Retrospective Cohort Study Using Clinical Care DataAmara Nassar-Sheikh Rashid, Femke Hooijberg, Sandy C Bergkamp, et al.Paediatric Drugs|July 15, 2026
Safety and Efficacy of Oral Ferric Maltol and Ferrous Sulfate for Iron Deficiency Anemia in Infants, Children and Adolescents: A Multicenter Randomized TrialDavid Gass, Andrew Freiberg, Marcus K H Auth, et al.Paediatric Drugs|July 27, 2026
21‑Valent Pneumococcal Conjugate Vaccine V116 (CAPVAXIVE®): Pediatric First ApprovalMatt ShirleyPaediatric Drugs|July 25, 2026
Effectiveness and Safety of IL-17A Inhibitors in Pediatric Psoriasis: A Real-World, Multicenter, International StudyVito Di Lernia, Bertille Bonniaud, Eve Puzenat, et al.Paediatric Drugs|September 22, 2026
Real-World Outcomes of Ocrelizumab and Ofatumumab Treatment in Pediatric-Onset Multiple SclerosisVivien X Xie Cherng, Claire Har, Hayley Roper, et al.Pageof 129